hotspot -WSS

hotspot

author：Wikipedia 2025-10-02 14:39:03 - browse：9451

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： How a scoliosis diagnosis changed the life of one young dancer

WSS

J&J to buy cancer drug developer Ambrx Biopharma

The FDA must approve intranasal treatments for anaphylaxis

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Midwives could help bridge maternal health disparities in the U.S.

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Medicare to pay more for cardiac rehab in hospital outpatient clinics

focus

hotspot

focus

Walensky prepares to leave CDC — and Congress — behind

David Liu startup to focus on CRISPR delivery

Heart attack and stroke risk calculators need revising

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

As demand for Covid shots wanes, Moderna seeks its next success

House panel takes first step toward fixing drug shortages

Tori Bowie and the unacceptable rates of Black maternal death

FDA weighs limits of animal data in assessing artificial wombs

As demand for Covid shots wanes, Moderna seeks its next success

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

leisure time

Why psychiatrists like me stop taking insurance

How the messy conversation about Dolly changed bioethics

Why the drug industry's warnings on the IRA's impact fall short

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

How a scoliosis diagnosis changed the life of one young dancer

explore

hotspot

focus

entertainment